Stroke Regenerative Medicine Center and Stroke Rehabilitation Center Relocate and Open New Bases within Osaka Medical University

Medical Corporation Taigakai relocated its Stroke Regenerative Medicine Center and Stroke Rehabilitation Center to Osaka Medical University in June 2025. This collaboration with the university, opening in April 2026, establishes a unique medical environment in Japan integrating medical education and practical regenerative medicine.
提携NQ 42/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 7, 2026 at 19:10
  • 🔍 Collected: May 7, 2026 at 10:31
  • 🤖 AI Analyzed: May 8, 2026 at 02:26 (15h 54m after Collected)
Medical Corporation Taigakai (Location: Higashisumiyoshi-ku, Osaka City; Chairman: Yasuo Fukutomi) relocated to Osaka Medical University in Yata, Higashisumiyoshi-ku, Osaka City, in June 2025, opening new bases for its Stroke Regenerative Medicine Center and Stroke Rehabilitation Center. Furthermore, Osaka Medical University, officially approved by the Ministry of Education, Culture, Sports, Science and Technology, opened in April 2026, creating a unique medical environment in Japan where medical education and the practical site of regenerative medicine are integrated.

1. Background and History of Relocation

Fukutomi Clinic, run by Medical Corporation Taigakai, became the first private hospital in Japan to start stroke regenerative medicine in 2012. Since then, for over 10 years, the clinic has been dedicated to spreading cutting-edge treatments. To deliver higher quality medical care to more patients, it relocated to Osaka Medical University in June 2025.
Accompanying this move, the "Stroke Regenerative Medicine Center" and "Stroke Rehabilitation Center" were newly established.
Osaka Medical University received approval from the Ministry of Education, Culture, Sports, Science and Technology in April 2026 (for the Department of Physical Therapy and Department of Nursing). By establishing the centers within the university's building, a system for organically connecting specialized education, research, and clinical practice in physical therapy has been put in place. We aim to further improve the quality of treatment and support for patients in an ideal environment for stroke treatment and rehabilitation.

Name
Stroke Regenerative Medicine Center / Stroke Rehabilitation Center

Relocation and Opening of New Bases
June 2025

Location
2-14-19 Yata, Higashisumiyoshi-ku, Osaka-shi 546-0023, Osaka Medical University Building 2, 1st Floor

Operating Corporation
Medical Corporation Taigakai

Director
Yasuo Fukutomi

Official Website (Regenerative Medicine)
https://www.apoplexy.jp/

Official Website (Rehabilitation)
https://www.apoplexy.jp/reha/

2. About the Opening of Osaka Medical University

In April 2026, Osaka Medical University (Tsukamoto Gakuin Educational Corporation and Osaka University of Arts Group) officially opened with permission from the Ministry of Education, Culture, Sports, Science and Technology. Advocating "100-year life era to 100-year health era," it established departments for physical therapy and nursing. With the educational philosophy of "Creating future medicine with technology x sensibility," it fosters medical professionals who will contribute to realizing a healthy longevity society.
The Stroke Regenerative Medicine Center's location within the university building is expected to facilitate collaboration with the Department of Physical Therapy's clinical training and research. This environment, where the next generation of medical professionals can learn about cutting-edge regenerative medicine firsthand, is believed to directly lead to an improvement in the quality of patient care.

3. Seven Features of the Stroke Regenerative Medicine Center

01. Japan's First Private Hospital to Offer Stroke Regenerative Medicine
In 2012, it became the first private hospital in Japan to start stroke regenerative medicine. Overcoming many difficulties, it established its unique treatment style and accumulated achievements as a pioneer.

02. Fully Customized Treatment that Stays Close to Patients
The director consistently oversees treatment from start to finish. It practices completely individualized care tailored to each patient's condition, way of thinking, and lifestyle.

03. Synergistic Effects of Regenerative Medicine x Specialized Rehabilitation
Physical therapists specializing in stroke are permanently stationed and implement individualized rehabilitation programs under the director's instructions. The goal is "to enable people who couldn't move to move again."

04. Cell Culture Processing Center (CPC) Conforming to Global GMP Standards
Equipped with a cell culture environment equivalent to pharmaceutical companies. It provides stem cell treatment with maximum assurance of safety and quality.

05. Repair and Regeneration of Nerves and Blood Vessels with Bone Marrow Stem Cells
Utilizes the repair function of the patient's own bone marrow stem cells to regenerate damaged nerves and blood vessels. It simultaneously aims for improvement of stroke after-effects and prevention of recurrence.

06. Joint Research with Two Universities
Joint research is conducted with Kansai Medical University on serum-free culture medium development and with Osaka Medical University using inspection equipment such as electroencephalography to evaluate the effectiveness of stroke regenerative medicine and explore new improvement methods. Through industry-academia collaboration in these two fields, the centers continuously verify and accumulate scientific evidence to improve treatment quality. Research is ongoing daily to provide the best possible treatment.

07. Certified by the Ministry of Health, Labour and Welfare as Japan's Second Private Medical Institution for Specific Certified Regenerative Medicine Committee
In 2016, Medical Corporation Taigakai received certification from the Ministry of Health, Labour and Welfare as the second private medical institution nationwide for a Specific Certified Regenerative Medicine Committee (Certification number: NA8150032). Treatment is provided under high safety standards and review systems.

4. Treatment Results
Regular check-ups and individualized rehabilitation guidance.
Treatment Start
Cumulative Number of Treatments
Symptom Improvement Rate (*1)
2012 (Japan's first for a private hospital)
Approx. 700 times
Approx. 90%
*1: Symptom improvement rate is based on the director's clinical evaluation (including SIAS test and WHO QOL test) and the patient's self-assessment regarding movements and functions that were difficult due to after-effects before treatment.